: This pharmaceutical company focuses on Parkinson's disease. Analysts give it a "Buy" rating with a $5.50 target price.
“TRX shares are trading below $2 and are up more than 300% over the past year... the stock's momentum has been supported by improving operational results rather than speculation alone.” FinanceBuzz · 3 months ago Best Stocks Under $2 Right Now - MarketBeat
Current market analysis as of , highlights several stocks under $2 with strong analyst consensus or significant momentum. These selections range from biopharmaceuticals to natural resources. Top Analyst-Rated Stocks Under $2
Beyond analyst ratings, some stocks show strong technical signals or sector-driven interest: